United Tyco's new coronary virus anti-medical test kit has been granted FDA emergency use authorization to further expand the global market.

Guide: United Tyco developed a new coronary virus anti-medical reagent, can be completed in 30 minutes the entire response to confirm whether the tested person is infected with the virus.
According to the Global New Crown Pneumonia Data Real-Time Statistics System released by Johns Hopkins University, as of 6 p.m. EST on August 19, a total of 5516,639 new coronary pneumonia cases and 172,667 deaths had been reported in the United States.
the past 24 hours, there have been 4,209 new confirmed cases and 1,151 new deaths in the United States.
, the U.S. epidemic situation remains critical, and the growing number of confirmed cases is behind the huge demand for new crown-testing reagents in the United States.
August 17, 2020, a new coronavirus anti-medical test kit (magnetic particle chemical luminescence method) developed by United Tyco was authorized by the FDA for emergency use, opening the door to the U.S. market and contributing to the global fight against the epidemic in China.
new coronary virus anti-medical reagent developed by United Tyco, the need for simultaneous detection of IgG and IgM antibodies can be achieved, with a full response within 30 minutes to confirm whether the person being tested is infected with the virus.
data show that the company developed IgM antibody detection clinical sensitivity of 99.1%, clinical specificity of up to 100%, IgG antibody detection clinical sensitivity of 95.5%, clinical specificity of 97.2%.
, the product has been CE certified, quickly sold to Italy, the Netherlands and other countries.
's FDA approval marks a further opening up of the global market by United Tyco.
"The company has entered into a full partnership with NASDAQ-listed Acerate Diagnostics, which, with its large sales force in the U.S. and Europe, can help the company's new coronary virus anti-medical reagents quickly enter the U.S. and European markets and help the global fight against the disease," said Li Feng, general manager of United Tyco.
, United Tyco has formed a close relationship with Biocheck corporation in the United States, the new coronary virus anti-medical test kit will be produced in the United States.
this way, you can save a lot of shipping time, while using the rapid response of the U.S.-based technical team to better serve local customers, the company's next U.S. declaration 510 (k) also helps.
: "The new crown virus detection will become a normal detection project in the future."
, antibody testing will become a routine testing program in fever clinics, on the other hand, after the vaccine is available, antibody testing is needed to determine whether the vaccine is effective.
", the market's demand against medical test kits becomes a continuing demand.
.